References
- Barbeau A. Experience clinique avec le tolbutamide dans la maladie de parkinson. Union Medecine Canadienne 1961; 90: 147–151
- Gillman M. A., Sandyk R. Tardive dyskinesia and glucose metabolism. Archives of General Psychiatry 1986; 43: 192–193
- Hansen J. M., Kristensen M. Insulin binding in four regions in the developing rat brain. Journal of Neurochemistry 1965; 42: 198–203
- Havrankova J., Roth J., Brownstein M. Insulin receptors are widely distributed in the central nervous system. Nature 1978; 272: 827–829
- Iversen L. L. Dopamine receptors in the brain. Science 1975; 188: 1084–1089
- Lozovsky D., Saller C. F., Kopin I. J. Dopamine receptor binding is increased in diabetic rats. Science 1981; 214: 1031–1032
- Lozovsky D., Saller C. F., Kopin I. J. Lithium and the prevention of dopamine receptor supersensitivity in diabetic rats. American Journal of Psychiatry 1983; 140: 613–614
- Mayeux R., Stern Y. Intellectual dysfunction and dementia in Parkinson's disease. Advances in neurology: the dementias, R. Mayeux, W. Rosen. Raven Press, New York 1983; Vol. 28
- Mukherjee S., Bilder R. M., Sack H. A. Reply. Archives of General Psychiatry, 43: 193
- Palovcik R. A., Phillips H. I., Kappy M. S., Raizada M. K. Insulin inhibits pyramidal neurons in hippocampal slices. Brain Research 1984; 309: 187–191
- Puro D. G., Agardh E. Insulin mediated regulation of neuronal maturation. Science 1984; 225: 1170–1172
- Quinn J. P., Lang A. E., Marsden C. D. Insulin-induced hypoglycemia does not abolish chorea. Journal of Neurology, Neurosurgery and Psychiatry 1982; 45: 936–843
- Rodbell M. Metabolism of isolated fat cells. Effects of hormones on glucose metabolism and lipolysis. Journal of Biological Chemistry 1964; 239: 375–380
- Saller C. F., Chiodo L. A. Glucose suppresses basal firing and haloperidol induced increases in the firing rate of central dopaminergic neurons. Science 1980; 210: 1269–1271
- Sandyk R., Bamford C. R., Rubens A. B. (in press). Neuroleptic-mediated hypothalamic deregulation of central insulin and peripheral glucose metabolism in tardive dyskinesia: A hypothesis. International Journal of Neuroscience
- Schwartz W. J., Sharp F. R., Gunn R. H., Evarts E. V. Lesions of ascending dopaminergic pathways decrease forebrain glucose uptake. Nature 1976; 261: 155–157
- Snyder E. Y., Kim S. U. Insulin: Is it a nerve survival factor. Brain Research 1980; 196: 565–571
- Szabo O., Szabo A. J. Studies on the nature and mode of action of the insulin-sensitive glucoregulator receptor in the central nervous system. Diabetes 1975; 24: 328–336
- Thorner M. D. Dopamine is an important neurotransmitter in the autonomic nervous system. Lancet 1975; 1: 662–665
- Trulson M. E., Himmel C. D. Decreased brain dopamine synthesis rate and increase [3H]-spiperidol binding in streptozocin-diabetic rats. Journal of Neurochemistry 1981; 40: 1456–1459
- Van Rooyen J. M., Offermeier J. Peripheral dopaminergic receptors: Physiological and pharmacological aspects of therapeutic importance. South African Medical Journal 1981; 59: 329–332
- Wolfson L. I., Leenders K. L., Brown L. L., Jones T. Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease. Neurology 1975; 35: 1399–1405